Trial Profile
The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study-
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2017
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Rebamipide (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 08 Jun 2017 Status changed from recruiting to completed.
- 02 Jan 2010 Planned number of patients changed from 240 to 100 as reported by University Hospital Medical Information Network - Japan.
- 03 Feb 2009 New trial record.